Nissim Darvish
CIK: 0001793602
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CMMB
Chemomab Therapeutics Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Darvish Nissim
Darvish Nissim (SEC CIK 0001793602) files insider reports with the SEC as Director of Chemomab Therapeutics Ltd. (CMMB).
Signal8 holds 1 ownership filing by Darvish Nissim, a Form 3, filed on Apr 10, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Darvish Nissim's filings is in TEL AVIV.
Other insiders filing for Chemomab Therapeutics Ltd. (CMMB)
- Cohen Neil Harris, Director
- Melincoff Gwen A, Director
- Mor George Adi, Chief Executive Officer
- Moses Alan Charles, Director
- Fatal Sigal, Chief Financial Officer
- Lawler John, Chief Development Officer